Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia

. 2020 Oct 01 ; 143 (10) : 2929-2944.

Jazyk angličtina Země Velká Británie, Anglie Médium print

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid32979048

Grantová podpora
K23 NS117310 NINDS NIH HHS - United States
U54 HD090255 NICHD NIH HHS - United States
R01 NS106298 NINDS NIH HHS - United States
R25 NS070682 NINDS NIH HHS - United States
Wellcome Trust - United Kingdom

Bi-allelic loss-of-function variants in genes that encode subunits of the adaptor protein complex 4 (AP-4) lead to prototypical yet poorly understood forms of childhood-onset and complex hereditary spastic paraplegia: SPG47 (AP4B1), SPG50 (AP4M1), SPG51 (AP4E1) and SPG52 (AP4S1). Here, we report a detailed cross-sectional analysis of clinical, imaging and molecular data of 156 patients from 101 families. Enrolled patients were of diverse ethnic backgrounds and covered a wide age range (1.0-49.3 years). While the mean age at symptom onset was 0.8 ± 0.6 years [standard deviation (SD), range 0.2-5.0], the mean age at diagnosis was 10.2 ± 8.5 years (SD, range 0.1-46.3). We define a set of core features: early-onset developmental delay with delayed motor milestones and significant speech delay (50% non-verbal); intellectual disability in the moderate to severe range; mild hypotonia in infancy followed by spastic diplegia (mean age: 8.4 ± 5.1 years, SD) and later tetraplegia (mean age: 16.1 ± 9.8 years, SD); postnatal microcephaly (83%); foot deformities (69%); and epilepsy (66%) that is intractable in a subset. At last follow-up, 36% ambulated with assistance (mean age: 8.9 ± 6.4 years, SD) and 54% were wheelchair-dependent (mean age: 13.4 ± 9.8 years, SD). Episodes of stereotypic laughing, possibly consistent with a pseudobulbar affect, were found in 56% of patients. Key features on neuroimaging include a thin corpus callosum (90%), ventriculomegaly (65%) often with colpocephaly, and periventricular white-matter signal abnormalities (68%). Iron deposition and polymicrogyria were found in a subset of patients. AP4B1-associated SPG47 and AP4M1-associated SPG50 accounted for the majority of cases. About two-thirds of patients were born to consanguineous parents, and 82% carried homozygous variants. Over 70 unique variants were present, the majority of which are frameshift or nonsense mutations. To track disease progression across the age spectrum, we defined the relationship between disease severity as measured by several rating scales and disease duration. We found that the presence of epilepsy, which manifested before the age of 3 years in the majority of patients, was associated with worse motor outcomes. Exploring genotype-phenotype correlations, we found that disease severity and major phenotypes were equally distributed among the four subtypes, establishing that SPG47, SPG50, SPG51 and SPG52 share a common phenotype, an 'AP-4 deficiency syndrome'. By delineating the core clinical, imaging, and molecular features of AP-4-associated hereditary spastic paraplegia across the age spectrum our results will facilitate early diagnosis, enable counselling and anticipatory guidance of affected families and help define endpoints for future interventional trials.

Amrita Institute of Medical Sciences and Research Centre Cochin India

Barrow Neurological Institute Phoenix Children's Hospital Phoenix AZ USA

Cambridge Institute for Medical Research University of Cambridge Cambridge UK

Cancer Research Center and Department of Medical Genetics Semnan University of Medical Sciences Semnan Iran

Center for Neurogenetics Weill Cornell Medical College New York NY USA

Center for Therapeutic Innovation and Department of Psychiatry and Behavioral Sciences University of Miami Miami FL USA

Centogene AG Rostock Germany

Child Neurology University of Rochester School of Medicine Rochester NY USA

CHU Lille Institut de Génétique Médicale RADEME Lille France

Clinical Genetics Human Genetics and Genome Research Division National Research Centre Cairo Egypt

Department of Biology and Medical Genetics 2nd Medical Faculty Charles University and UH Motol Prague Czech Republic

Department of General Pediatrics University Children's Hospital Muenster Muenster Germany

Department of Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Uppsala Sweden

Department of Medical Genetics Kasturba Medical College Manipal Academy of Higher Education Manipal India

Department of Molecular Neuroscience UCL Institute of Neurology London UK

Department of Neurology Boston Children's Hospital Harvard Medical School Boston MA USA

Department of Neurology Papageorgiou Hospital Thessaloniki Greece

Department of Neurology University Hospital Würzburg Würzburg Germany

Department of Neurology University of Texas Southwestern Medical Center Dallas TX USA

Department of Neurology University of Yamanashi Yamanashi Japan

Department of Neurology Washington University School of Medicine St Louis MO USA

Department of Paediatrics The Hospital for Sick Children and The University of Toronto Toronto Canada

Department of Pediatric Neurology Jaslok Hospital and Research Centre Mumbai India

Department of Pediatrics Seattle Children's Hospital University of Washington School of Medicine Seattle WA USA

Division of Child Neurology and Metabolic Medicine Centre for Paediatric and Adolescent Medicine University Hospital Heidelberg Heidelberg Germany

Division of Child Neurology Weill Cornell Medicine New York City NY USA

Division of Clinical and Metabolic Genetics Department of Paediatrics The Hospital for Sick Children University of Toronto Toronto Canada

Division of Genetic Medicine Department of Pediatrics University of Washington Seattle WA USA

Division of Neurology Department of Pediatrics University of Iowa Carver College of Medicine Iowa City IA USA

Divisions of Newborn Medicine and Genetics and Genomics The Manton Center for Orphan Disease Research Boston Children's Hospital Harvard Medical School Boston MA USA

Genetic Health Queensland Royal Brisbane and Women's Hospital Brisbane Australia

Grupo de Medicina Xenómica CIBERER Santiago de Compostela Spain

Institute of Human Genetics Friedrich Alexander Universität Erlangen Nürnberg Erlangen Germany

Institute of Human Genetics University Hospital Leipzig Leipzig Germany

Medical Genetics Centre Hospitalier Universitaire de Liège Liège Belgium

Molecular Medicine IRCCS Fondazione Stella Maris Pisa Italy

Movement Disorders Clinic Pediatric Neurology Unit Wolfson Medical Center Holon Sackler School of Medicine Tel Aviv University Israel

Neonatal Research Center Shiraz University of Medical Sciences Shiraz Iran

Neurogenetics Group and Neuromuscular Reference Center University of Antwerp and Antwerp University Hospital Antwerp Belgium

Neurología Pediátrica Complexo Hospitalario Universitario Santiago de Compostela Spain

Pediatric Genetics Department of Pediatrics Acibadem Mehmet Ali Aydinlar University Istanbul Turkey

Pediatric Medical Genetics Maria Fareri Children's Hospital Valhalla NY USA

Pediatric Neurology and Developmental Medicine Dr v Hauner Children's Hospital Ludwig Maximilians University Munich Germany

Pediatric Neurology Cairo University Cairo Egypt

Pediatric Neurology CHU Montpellier Montpellier France

Pediatric Neurology Dr Sami Ulus Hospital Ankara Turkey

Pediatric Neurology Faculty of Medicine Sohag University Sohag Egypt

Pediatric Neurology Ghent University Hospital Ghent Belgium

Pediatric Neurology Istanbul Medical Faculty Istanbul Turkey

Pediatric Neurology Medanta Hospital Indore India

Pediatric Neurology National Neuroscience Institute King Fahad Medical City Riyadh Saudi Arabia

Pediatric Neurology Saarland University Medical Center Homburg Saar Germany

Pediatric Neurology Unit Department of Pediatrics UZ Brussel Brussels Belgium

Pediatrics Ain Shams University Cairo Egypt

Pediatrics Evangelisches Krankenhaus Oberhausen Oberhausen Germany

Pediatrics Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia

Persian BayanGene Research and Training Center Shiraz University of Medical Sciences Shiraz Iran

Rady Children's Institute for Genomic Medicine Rady Children's Hospital San Diego CA USA

Scientific Institute IRCCS E Medea Unità Operativa Conegliano Treviso Italy

Service de Neurologie Hôpitaux Universitaires de Strasbourg Strasbourg France

Serviço de Genética Médica Universidade Federal da Bahia Salvador Brazil

Sozialpädiatrisches Zentrum Hannover Hannover Germany

Translational Neuroscience Celgene Cambridge MA USA

Translational Neuroscience Center Boston Children's Hospital Harvard Medical School Boston MA USA

Komentář v

PubMed

Erratum v

PubMed

Zobrazit více v PubMed

Abou Jamra R, Philippe O, Raas-Rothschild A, Eck SH, Graf E, Buchert R, et al.Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 2011; 88: 788–95. PubMed PMC

Accogli A, Hamdan FF, Poulin C, Nassif C, Rouleau GA, Michaud JL, et al.A novel homozygous AP4B1 mutation in two brothers with AP-4 deficiency syndrome and ocular anomalies. Am J Med Genet A 2018; 176: 985–91. PubMed

Aguilar RC, Boehm M, Gorshkova I, Crouch RJ, Tomita K, Saito T, et al.Signal-binding specificity of the mu4 subunit of the adaptor protein complex AP-4. J Biol Chem 2001; 276: 13145–52. PubMed

Appleton RE, Gupta R. Cerebral palsy: not always what it seems. Arch Dis Child 2019; 104: 809–14. PubMed

Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA 2006; 296: 1602–8. PubMed

Behne R, Teinert J, Wimmer M, D’Amore A, Davies AK, Scarrott JM, et al.Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Hum Mol Genet 2020; 29: 320–34. PubMed PMC

Blackstone C. Hereditary spastic paraplegia. Handb Clin Neurol. 2018; 148: 633–52. PubMed

Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–7. PubMed

Burgos PV, Mardones GA, Rojas AL, daSilva LL, Prabhu Y, Hurley JH, et al.Sorting of the Alzheimer's disease amyloid precursor protein mediated by the AP-4 complex. Dev Cell 2010; 18: 425–36. PubMed PMC

Chrestian N, Dupre N, Gan-Or Z, Szuto A, Chen S, Venkitachalam A, et al.Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet 2017; 3: e122. PubMed PMC

da Graca FF, de Rezende TJR, Vasconcellos LFR, Pedroso JL, Barsottini OGP, Franca MC Jr.. Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. Front Neurol 2018; 9: 1117. PubMed PMC

Ebrahimi-Fakhari D. Congenital disorders of autophagy: what a pediatric neurologist should know. Neuropediatrics 2018; 49: 18–25. PubMed

Ebrahimi-Fakhari D, Behne R, Davies AK, Hirst J. AP-4-associated hereditary spastic paraplegia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews((R)). Seattle (WA: ); 2018a. PubMed

Ebrahimi-Fakhari D, Cheng C, Dies K, Diplock A, Pier DB, Ryan CS, et al.Clinical and genetic characterization of AP4B1-associated SPG47. Am J Med Genet A 2018b; 176: 311–8. PubMed

Ebrahimi-Fakhari D, Saffari A, Wahlster L, Lu J, Byrne S, Hoffmann GF, et al.Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism. Brain 2016; 139: 317–37. PubMed PMC

Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain 2009; 132: 1577–88. PubMed

Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al.DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet 2009; 84: 524–33. PubMed PMC

Hardies K, May P, Djemie T, Tarta-Arsene O, Deconinck T, Craiu D, et al.Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly. Hum Mol Genet 2015; 24: 2218–27. PubMed PMC

Hirst J, Bright NA, Rous B, Robinson MS. Characterization of a fourth adaptor-related protein complex. Mol Biol Cell 1999; 10: 2787–802. PubMed PMC

Kara E, Tucci A, Manzoni C, Lynch DS, Elpidorou M, Bettencourt C, et al.Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain 2016; 139: 1904–18. PubMed PMC

Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z, et al.Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease. Neuron 2015; 88: 499–513. PubMed PMC

Karle KN, Schule R, Klebe S, Otto S, Frischholz C, Liepelt-Scarfone I, et al.Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP). Orphanet J Rare Dis 2013; 8: 158. PubMed PMC

Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310–5. PubMed PMC

Kong XF, Bousfiha A, Rouissi A, Itan Y, Abhyankar A, Bryant V, et al.A novel homozygous p.R1105X mutation of the AP4E1 gene in twins with hereditary spastic paraplegia and mycobacterial disease. PLoS One 2013; 8: e58286. PubMed PMC

Kwong KL, Wong YC, Fong CM, Wong SN, So KT. Magnetic resonance imaging in 122 children with spastic cerebral palsy. Pediatr Neurol 2004; 31: 172–6. PubMed

Lamichhane DM. New AP4B1 mutation in an African-American child associated with intellectual disability. J Pediatr Genet 2013; 2: 191–5. PubMed PMC

Langouet M, Siquier-Pernet K, Sanquer S, Bole-Feysot C, Nitschke P, Boddaert N, et al.Contiguous mutation syndrome in the era of high-throughput sequencing. Mol Genet Genomic Med 2015; 3: 215–20. PubMed PMC

Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek CD. Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. Orphanet J Rare Dis 2014; 9: 197. PubMed PMC

Leventer RJ, Jansen A, Pilz DT, Stoodley N, Marini C, Dubeau F, et al.Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain 2010; 133: 1415–27. PubMed PMC

Moreno-De-Luca A, Helmers SL, Mao H, Burns TG, Melton AM, Schmidt KR, et al.Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 2011; 48: 141–4. PubMed PMC

Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, et al.Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011; 478: 57–63. PubMed

Pearson TS, Pons R, Ghaoui R, Sue CM. Genetic mimics of cerebral palsy. Mov Disord 2019; 34: 625–36. PubMed

Pensato V, Castellotti B, Gellera C, Pareyson D, Ciano C, Nanetti L, et al.Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 2014; 137: 1907–20. PubMed

Rana KS, Narwal V, Chauhan L, Singh G, Sharma M, Chauhan S. Structural and perfusion abnormalities of brain on MRI and technetium-99m-ECD SPECT in children with cerebral palsy: a comparative study. J Child Neurol 2016; 31: 589–92. PubMed

Roubertie A, Hieu N, Roux CJ, Leboucq N, Manes G, Charif M, et al.AP4 deficiency: a novel form of neurodegeneration with brain iron accumulation? Neurol Genet 2018; 4: e217. PubMed PMC

Schule R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V, et al.The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity. Neurology 2006; 67: 430–4. PubMed

Shain C, Ramgopal S, Fallil Z, Parulkar I, Alongi R, Knowlton R, et al.Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the epilepsy phenome/genome project. Epilepsia 2013; 54: 1368–75. PubMed PMC

Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, et al.Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008; 131: 772–84. PubMed

Stutterd CA, Leventer RJ. Polymicrogyria: a common and heterogeneous malformation of cortical development. Am J Med Genet C Semin Med Genet 2014; 166C: 227–39. PubMed

Tan CA, Topper S, Del Gaudio D, Nelakuditi V, Shchelochkov O, Nowaczyk MJM, et al.Characterization of patients referred for non-specific intellectual disability testing: the importance of autosomal genes for diagnosis. Clin Genet 2016; 89: 478–83. PubMed

Tessa A, Battini R, Rubegni A, Storti E, Marini C, Galatolo D, et al.Identification of mutations in AP4S1/SPG52 through next generation sequencing in three families. Eur J Neurol 2016; 23: 1580–7. PubMed

Toh WH, Tan JZ, Zulkefli KL, Houghton FJ, Gleeson PA. Amyloid precursor protein traffics from the Golgi directly to early endosomes in an Arl5b- and AP4-dependent pathway. Traffic 2017; 18: 159–75. PubMed

Trujillano D, Oprea GE, Schmitz Y, Bertoli-Avella AM, Abou Jamra R, Rolfs A. A comprehensive global genotype-phenotype database for rare diseases. Mol Genet Genomic Med 2017; 5: 66–75. PubMed PMC

Tuysuz B, Bilguvar K, Kocer N, Yalcinkaya C, Caglayan O, Gul E, et al.Autosomal recessive spastic tetraplegia caused by AP4M1 and AP4B1 gene mutation: expansion of the facial and neuroimaging features. Am J Med Genet A 2014; 164A: 1677–85. PubMed

Verkerk AJ, Schot R, Dumee B, Schellekens K, Swagemakers S, Bertoli-Avella AM, et al.Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 2009; 85: 40–52. PubMed PMC

Vill K, Muller-Felber W, Alhaddad B, Strom TM, Teusch V, Weigand H, et al.A homozygous splice variant in AP4S1 mimicking neurodegeneration with brain iron accumulation. Mov Disord 2017; 32: 797–9. PubMed

Wild B, Rodden FA, Grodd W, Ruch W. Neural correlates of laughter and humour. Brain 2003; 126: 2121–38. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace